Showing 20,121 - 20,140 results of 145,922 for search '(( i we decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 2.17s Refine Results
  1. 20121

    Image4_Analysis of Geometric and Hemodynamic Profiles in Rat Arteriovenous Fistula Following PDE5A Inhibition.tif by Hannah Northrup (5938436)

    Published 2021
    “…In both groups: 1) CSA increased from the 0–5 to 15–20 zone; 2) velocity, WSS, and vorticity were highest in the 0–5 zone and dropped significantly thereafter; and 3) OSI increased at the 5–10 zone and then decreased gradually. …”
  2. 20122

    Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease by Mattia Cocco (1697905)

    Published 2017
    “…The in vitro determination of reactivity, cytotoxicity, NLRP3 ATPase inhibition, and antipyroptotic properties allowed the selection of <b>11</b> (INF39), a nontoxic, irreversible NLRP3 inhibitor able to decrease interleukin-1β release from macrophages. Bioluminescence resonance energy transfer experiments proved that this compound was able to directly interfere with NLRP3 activation in cells. …”
  3. 20123

    Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

    Published 2023
    “…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”
  4. 20124

    Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

    Published 2023
    “…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”
  5. 20125

    Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

    Published 2023
    “…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”
  6. 20126

    Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment by Jinxin Che (791250)

    Published 2023
    “…Treatment with <b>B12</b> results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. …”
  7. 20127

    Image_5_The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA.TIF by Ligang Zhang (830488)

    Published 2021
    “…Immunization with Peptibody could elicit high-titer anti-bFGF and anti-VEGFA antibodies, activate T cells, and induce Th1/Th2-type cytokines. In in vitro experiments, the isolated anti-Peptibody antibody inhibited the proliferation and migration of A549 cells and human umbilical vein endothelial cells (HUVECs) by decreasing the MAPK/Akt/mTOR signal pathways. …”
  8. 20128

    Image_5_The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA.TIF by Ligang Zhang (830488)

    Published 2020
    “…Immunization with Peptibody could elicit high-titer anti-bFGF and anti-VEGFA antibodies, activate T cells, and induce Th1/Th2-type cytokines. In in vitro experiments, the isolated anti-Peptibody antibody inhibited the proliferation and migration of A549 cells and human umbilical vein endothelial cells (HUVECs) by decreasing the MAPK/Akt/mTOR signal pathways. …”
  9. 20129

    Table5_MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis.DOCX by Jéssica Henrique De Freitas (15215455)

    Published 2023
    “…PTEN levels increased, NO and ROS decreased in SLs from dogs with CanL. Inhibition of miRNA-21 resulted in PTEN increase; in contrast, PTEN decreased after miR-148a inhibition. …”
  10. 20130

    Image_5_MoMih1 is indispensable for asexual development, cell wall integrity, and pathogenicity of Magnaporthe oryzae.tif by Shiyi Liu (1702921)

    Published 2023
    “…We here functionally characterized the Mih1 homologue MoMih1 in M. oryzae. …”
  11. 20131
  12. 20132

    Quality evaluation of incorporated literature. by Rongrong Han (9258298)

    Published 2024
    “…</p><p>Results</p><p>Twenty-one RCTs were included in this Meta-analysis. The Meta-analysis indicated that early tracheotomy could significantly shorten the duration of mechanical ventilation (MD: -2.77; 95% CI -5.10~ -0.44; <i>P</i> = 0.02) and the length of ICU stay (MD: -6.36; 95% CI -9.84~ -2.88; <i>P</i> = 0.0003), but it did not significantly alter the all-cause mortality (RR 0.86; 95% CI 0.73~1.00; <i>P</i> = 0.06), the incidence of pneumonia (RR 0.86; 95% CI 0.74~1.01; <i>P</i> = 0.06), and length of hospital stay (MD: -3.24; 95% CI -7.99~ 1.52; <i>P</i> = 0.18).…”
  13. 20133

    Publish bias funnel plots of pneumonia. by Rongrong Han (9258298)

    Published 2024
    “…</p><p>Results</p><p>Twenty-one RCTs were included in this Meta-analysis. The Meta-analysis indicated that early tracheotomy could significantly shorten the duration of mechanical ventilation (MD: -2.77; 95% CI -5.10~ -0.44; <i>P</i> = 0.02) and the length of ICU stay (MD: -6.36; 95% CI -9.84~ -2.88; <i>P</i> = 0.0003), but it did not significantly alter the all-cause mortality (RR 0.86; 95% CI 0.73~1.00; <i>P</i> = 0.06), the incidence of pneumonia (RR 0.86; 95% CI 0.74~1.01; <i>P</i> = 0.06), and length of hospital stay (MD: -3.24; 95% CI -7.99~ 1.52; <i>P</i> = 0.18).…”
  14. 20134

    Subgroup analyses for incidence of pneumonia. by Rongrong Han (9258298)

    Published 2024
    “…</p><p>Results</p><p>Twenty-one RCTs were included in this Meta-analysis. The Meta-analysis indicated that early tracheotomy could significantly shorten the duration of mechanical ventilation (MD: -2.77; 95% CI -5.10~ -0.44; <i>P</i> = 0.02) and the length of ICU stay (MD: -6.36; 95% CI -9.84~ -2.88; <i>P</i> = 0.0003), but it did not significantly alter the all-cause mortality (RR 0.86; 95% CI 0.73~1.00; <i>P</i> = 0.06), the incidence of pneumonia (RR 0.86; 95% CI 0.74~1.01; <i>P</i> = 0.06), and length of hospital stay (MD: -3.24; 95% CI -7.99~ 1.52; <i>P</i> = 0.18).…”
  15. 20135

    Publish bias funnel plots of mortality. by Rongrong Han (9258298)

    Published 2024
    “…</p><p>Results</p><p>Twenty-one RCTs were included in this Meta-analysis. The Meta-analysis indicated that early tracheotomy could significantly shorten the duration of mechanical ventilation (MD: -2.77; 95% CI -5.10~ -0.44; <i>P</i> = 0.02) and the length of ICU stay (MD: -6.36; 95% CI -9.84~ -2.88; <i>P</i> = 0.0003), but it did not significantly alter the all-cause mortality (RR 0.86; 95% CI 0.73~1.00; <i>P</i> = 0.06), the incidence of pneumonia (RR 0.86; 95% CI 0.74~1.01; <i>P</i> = 0.06), and length of hospital stay (MD: -3.24; 95% CI -7.99~ 1.52; <i>P</i> = 0.18).…”
  16. 20136

    Study inclusion flowchart. by Rongrong Han (9258298)

    Published 2024
    “…</p><p>Results</p><p>Twenty-one RCTs were included in this Meta-analysis. The Meta-analysis indicated that early tracheotomy could significantly shorten the duration of mechanical ventilation (MD: -2.77; 95% CI -5.10~ -0.44; <i>P</i> = 0.02) and the length of ICU stay (MD: -6.36; 95% CI -9.84~ -2.88; <i>P</i> = 0.0003), but it did not significantly alter the all-cause mortality (RR 0.86; 95% CI 0.73~1.00; <i>P</i> = 0.06), the incidence of pneumonia (RR 0.86; 95% CI 0.74~1.01; <i>P</i> = 0.06), and length of hospital stay (MD: -3.24; 95% CI -7.99~ 1.52; <i>P</i> = 0.18).…”
  17. 20137
  18. 20138
  19. 20139

    Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of <i>Mycobacterium tuberculosis</i> by Susanta Pahari (37943)

    Published 2019
    “…</p> <p>3MA: 3 methyladenine; AO: acridine orange; Atg5: autophagy related 5; AVOs: acidic vesicular organelles; BECN1: beclin 1, autophagy related; BMDMs: bone marrow derived macrophages; bw: body weight; C<sub>4</sub>.T<sub>4</sub>: agonists of CLEC4E (C<sub>4</sub>/TDB) and TLR4 (T<sub>4</sub>/ultra-pure-LPS); CFU: colony forming unit; CLEC4E/Mincle: C-type lectin domain family 4, member e; CLR: c-type lectin receptor; INH: isoniazid; LAMP1: lysosomal-associated membrane protein 1; Mφ<sup>C4.T4</sup>: <i>Mtb-</i>infected C<sub>4</sub>.T<sub>4</sub> stimulated macrophages; MAP1LC3/LC3: microtubule-associated protein 1 light chain 3; MDC: monodansylcadaverine; MTOR: mechanistic target of rapamycin kinase; MYD88: myeloid differentiation primary response 88; NFKB: nuclear factor of kappa light polypeptide gene enhance in B cells; NLR: NOD (nucleotide-binding oligomerization domain)-like receptors; PFA: paraformaldehyde; PPD: purified protein derivative; PtdIns3K: class III phosphatidylinositol 3-kinase; RELA: v-rel reticuloendotheliosis viral oncogene homolog A (avian); RIF: rifampicin; RLR: retinoic acid-inducible gene-I-like receptors; TDB: trehalose-6,6´-dibehenate; TLR4: toll-like receptor 4; Ultra-pure-LPS: ultra-pure lipopolysaccharide-EK; V-ATPase: vacuolar-type H<sup>+</sup> ATPase.…”
  20. 20140

    TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models by Yoshinori Tsumura (3753757)

    Published 2017
    “…However, clinical development of GK activators has failed due to the loss of glucose-lowering effects and increased plasma triglyceride levels after chronic treatment. Here, we generated a novel GK activator, TMG-123, examined its <i>in vitro</i> and <i>in vivo</i> pharmacological characteristics, and evaluated its risks of aforementioned clinical issues. …”